ENDRA Life Sciences
NDRA
11 hedge funds and large institutions have $6.06M invested in ENDRA Life Sciences in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
21% less funds holding
Funds holding: 14 → 11 (-3)
22% less capital invested
Capital invested by funds: $7.75M → $6.06M (-$1.69M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$63.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$104K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$65K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$63.9K |
| 4 |
TP
Tranquility Partners
Brentwood,
Tennessee
|
-$28K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$27K |
NDRA Hedge Fund Activity: Q3 2021 in Review
11 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2021, worth a combined $6.06M — down 22% from $7.75M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NDRA and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was State Street, adding an estimated $63.9K. The largest seller was Goldman Sachs, exiting entirely with an estimated $104K sold.
- 11 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2021, down from 14 in Q2 2021.
- Funds reported $6.06M of ENDRA Life Sciences stock for Q3 2021, down 22% quarter-over-quarter.
- 0 funds opened new ENDRA Life Sciences positions in Q3 2021 and 3 closed out, a net change of -3 holders.
- The largest ENDRA Life Sciences buyer in Q3 2021 was State Street, an estimated $63.9K added.
- The largest ENDRA Life Sciences seller in Q3 2021 was Goldman Sachs, an estimated $104K sold.
Based on aggregated 13F filings for Q3 2021.